Less is More in Antithrombotic Therapy for Durable Left Ventricular
Assist Devices

Matthew   T.   Brown; Nanette   K.   Wenger

doi:10.2174/011573403X307310240404062647

[1]
Brown MT, Bortfeld KS, Sperling LS, Wenger NK. Redefining the roles of aspirin across the spectrum of cardiovascular disease prevention. Curr Cardiol Rev  2023; 19(6): 9-22.
 [PMID:  37132104]

[2]
Consolo F, Lucchetti RM, Tramontin C, Lapenna E, Pappalardo F. Do we need aspirin in HeartMate 3 patients? Eur J Heart Fail  2019; 21(6): 815-7.
 [http://dx.doi.org/10.1002/ejhf.1468] [PMID:  30983057]

[3]
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation  2021; 143(5): e72-e227.
 [PMID:  33332150]

[4]
Shah P, Tantry US, Bliden KP, Gurbel PA. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant  2017; 36(11): 1164-73.
 [http://dx.doi.org/10.1016/j.healun.2017.05.008] [PMID:  28579115]

[5]
Del Rio-Pertuz G, Nair N. Gastrointestinal bleeding in patients with continuous‐flow left ventricular assist devices: A comprehensive review. Artif Organs  2023; 47(1): 12-23.
 [http://dx.doi.org/10.1111/aor.14432] [PMID:  36334280]

[6]
Tedford RJ, Leacche M, Lorts A, Drakos SG, Pagani FD, Cowger J. Durable mechanical circulatory support. J Am Coll Cardiol  2023; 82(14): 1464-81.
 [http://dx.doi.org/10.1016/j.jacc.2023.07.019] [PMID:  37758441]

[7]
Mehra MR, Netuka I, Uriel N, et al. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure. JAMA  2023; 330(22): 2171-81.
 [http://dx.doi.org/10.1001/jama.2023.23204] [PMID:  37950897]

[8]
Agarwal N, Mahmoud AN, Patel NK, et al. Meta-analysis of aspirin versus dual antiplatelet therapy following coronary artery bypass grafting. Am J Cardiol  2018; 121(1): 32-40.
 [http://dx.doi.org/10.1016/j.amjcard.2017.09.022] [PMID:  29122278]

[9]
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation  2019; 140(11): e563-95.
 [http://dx.doi.org/10.1161/CIR.0000000000000677] [PMID:  30879339]

[10]
Davidson KW, Barry MJ, Mangione CM, et al. Aspirin use to prevent cardiovascular disease. JAMA  2022; 327(16): 1577-84.
 [http://dx.doi.org/10.1001/jama.2022.4983] [PMID:  35471505]

[11]
Gragnano F, Cao D, Pirondini L, et al. P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. J Am Coll Cardiol  2023; 82(2): 89-105.
 [http://dx.doi.org/10.1016/j.jacc.2023.04.051] [PMID:  37407118]

[12]
Knijnik L, Fernandes M, Rivera M, et al. Meta-analysis of duration of dual antiplatelet therapy in acute coronary syndrome treated with coronary stenting. Am J Cardiol  2021; 151: 25-9.
 [http://dx.doi.org/10.1016/j.amjcard.2021.04.014] [PMID:  34049672]

[13]
O’Donoghue ML, Murphy SA, Sabatine MS. The safety and efficacy of aspirin discontinuation on a background of a P2Y 12 inhibitor in patients after percutaneous coronary intervention. Circulation  2020; 142(6): 538-45.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046251] [PMID:  32551860]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/011573403X307310240404062647	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557

Current Cardiology Reviews

Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices

Related Journals

Related Books